Publicacións (17) Publicacións de Elisa Pilar Izquierdo Delgado

2024

  1. Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile

    Neuro-oncology, Vol. 26, Núm. 9, pp. 1723-1737

2022

  1. Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

    Clinical and Translational Oncology, Vol. 24, Núm. 5, pp. 809-815

  2. DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition

    Cancer Discovery, Vol. 12, Núm. 3, pp. 712-729

  3. FGF7–FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomas

    Molecular Oncology, Vol. 16, Núm. 6, pp. 1272-1289

  4. Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study

    JCO Precision Oncology, Vol. 6

2021

  1. Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patients

    Neuro-Oncology Advances, Vol. 3, Núm. 1

  2. Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium

    Journal of Clinical Oncology, Vol. 39, Núm. 26, pp. 2859-2871

2020

  1. Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes

    Cancer Discovery, Vol. 10, Núm. 7, pp. 942-963

2019

  1. A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations

    European Journal of Cancer, Vol. 121, pp. 224-235

2018

  1. Comprehensive molecular characterisation of epilepsy-associated glioneuronal tumours

    Acta Neuropathologica, Vol. 135, Núm. 1, pp. 115-129

  2. Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial

    Cancer Cell, Vol. 33, Núm. 5, pp. 829-842.e5

  3. The ten-year evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusion

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours

    Oncotarget, Vol. 8, Núm. 67, pp. 112036-112050

  2. Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma

    Cancer Cell, Vol. 32, Núm. 4, pp. 520-537.e5

2013

  1. Lung adenocarcinoma in the era of targeted therapies: Histological classification, sample prioritization, and predictive biomarkers

    Clinical and Translational Oncology, Vol. 15, Núm. 7, pp. 503-508

  2. The ALK translocation in advanced non-small-cell lung carcinomas: Preapproval testing experience at a single cancer centre

    Histopathology, Vol. 62, Núm. 4, pp. 609-616

2012

  1. A comparison of EGFR mutation testing methods in lung carcinoma: Direct sequencing, real-time PCR and immunohistochemistry

    PLoS ONE, Vol. 7, Núm. 8